|Last Price$9.30||Day Change (%)-0.11%|
|Open Price$9.30||Day Change ($)-0.01|
|Day Range9.30–9.30||52-Week Range8.59–9.34|
As of Tue 07/26/2016 | USD
Favorable conditions are in place for merger-arbitrage ETFs, including increasing M&A activity and the likelihood of higher interest rates.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
We'd prefer a pack of gum to these businesses.
Three ways to separate long-term winners from stocks that fizzle.